Literature DB >> 1613613

Variation in physician opinion about scheduling of return visits for common ambulatory care conditions.

J K Tobacman1, R R Zeitler, A M Cilursu, M Mori.   

Abstract

OBJECTIVE: To determine whether there is consensus about intervals between visits for adult general medicine patients with common ambulatory care conditions.
DESIGN: Survey of practicing physicians and residents.
SETTING: Ambulatory care at a hospital clinic, a group practice, and a physician office. PARTICIPANTS: 153 physicians, including residents, fellows, and staff from The University of Iowa Hospitals and Clinics, internists and family practitioners from three Iowa towns, and internists from Atlantic City, New Jersey.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: There was wide variation in responses, with greater consensus for more acute conditions than for chronic conditions or preventive care.
CONCLUSIONS: 1) Wide variation exists in proposed intervals between visits for care of patients with common ambulatory conditions. 2) Variation occurs within the same geographic area and is unassociated with year of graduation from medical school, year in training, or academic appointment 3) Further study is needed to assess the significance of this variation.

Entities:  

Mesh:

Year:  1992        PMID: 1613613     DOI: 10.1007/bf02598090

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  1 in total

1.  The content of ambulatory medical care in the United States. An interspecialty comparison.

Authors:  R A Rosenblatt; D C Cherkin; R Schneeweiss; L G Hart
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

  1 in total
  11 in total

1.  The role of patients and providers in the timing of follow-up visits. Telephone Care Study Group.

Authors:  H G Welch; M K Chapko; K E James; L M Schwartz; S Woloshin
Journal:  J Gen Intern Med       Date:  1999-04       Impact factor: 5.128

2.  Return-visit intervals.

Authors:  G H Gordon
Journal:  J Gen Intern Med       Date:  1993-02       Impact factor: 5.128

3.  Who's in charge here? Maximizing patient benefit and professional authority by physician limit setting.

Authors:  H G Welch; J L Bernat; R P Mogielnicki
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

4.  Revisit frequency and its association with quality of care among diabetic patients: Translating Research Into Action for Diabetes (TRIAD).

Authors:  Keiko Asao; Laura N McEwen; Jesse C Crosson; Beth Waitzfelder; William H Herman
Journal:  J Diabetes Complications       Date:  2014-06-19       Impact factor: 2.852

5.  A computerized intervention to improve timing of outpatient follow-up: a multicenter randomized trial in patients treated with warfarin. National Consortium of Anticoagulation Clinics.

Authors:  S D Fihn; M B McDonell; D Vermes; J G Henikoff; D C Martin; C M Callahan; D L Kent; R H White
Journal:  J Gen Intern Med       Date:  1994-03       Impact factor: 5.128

6.  Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners.

Authors:  Richard V Birtwhistle; Marshall S Godwin; M Dianne Delva; R Ian Casson; Miu Lam; Susan E MacDonald; Rachelle Seguin; Lucia Rühland
Journal:  BMJ       Date:  2004-01-15

7.  Setting the revisit interval in primary care.

Authors:  L M Schwartz; S Woloshin; J H Wasson; R A Renfrew; H G Welch
Journal:  J Gen Intern Med       Date:  1999-04       Impact factor: 5.128

8.  Survivors of motor vehicle trauma: an analysis of seat belt use and health care utilization.

Authors:  D A Redelmeier; P J Blair
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

9.  A general method for identifying excess revisit rates: the case of hypertension.

Authors:  Norman Frohlich; Marilyn Cree; K C Carriere
Journal:  Healthc Policy       Date:  2008-02

10.  Visit frequency and hypertension.

Authors:  Richard Guthmann; Nancy Davis; Matthew Brown; Jose Elizondo
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.